Approval for the gore viabahn endoprosthesis and gore viabahn endoprosthesis with heparin bioactive surface. these devices are indicated for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery de novo and restenotic lesions up to 270 mm in length with reference vessel diameters ranging from 4.0  7.5 mm.  These devices are also indicated for improving blood flow in patients with symptomatic peripheral arterial disease in  superficial femoral artery in-stent restenotic lesions up to 270 mm in length with reference vessel diameters ranging from 4.0  6.5 mm.